Research has shown that circFAM13B competes with PKM2 to bind to the KH3-4 domain of IGF2BP1, leading to the attenuation of PKM2 expression in bladder cancer 16. The gene discussed is IGF2BP1; the disease is urinary bladder carcinoma.